Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients.
Xu J, Isaacs WB, Mamawala M, Shi Z, Landis P, Petkewicz J, Wei J, Wang CH, Resurreccion WK, Na R, Bhanji Y, Novakovic K, Walsh PC, Zheng SL, Helfand BT, Pavlovich CP. Xu J, et al. Among authors: mamawala m. Prostate. 2021 Jul;81(10):703-709. doi: 10.1002/pros.24140. Epub 2021 May 6. Prostate. 2021. PMID: 33956350 Free PMC article.
Reply to Weigang Yan, Zhien Zhou, Hanzhong Li's Letter to the Editor re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81.
Tosoian JJ, Trock BJ, Ballentine Carter H, Mamawala M. Tosoian JJ, et al. Among authors: mamawala m. Eur Urol. 2017 Jan;71(1):e13. doi: 10.1016/j.eururo.2016.05.037. Epub 2016 Jun 13. Eur Urol. 2017. PMID: 27311363 No abstract available.
Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, Carter HB.J Clin Oncol. 2015 Oct 20;33(30):3379-85. [Epub 2015 Aug 31]. doi: 10.1200/JCO.2015.62.5764.
Scott E, Mamawala M, Epstein JI, Landis P, Wolf S, Trock, Carter HB. Scott E, et al. Among authors: mamawala m. Urol Oncol. 2017 Mar;35(3):121-122. doi: 10.1016/j.urolonc.2016.12.019. Epub 2017 Feb 1. Urol Oncol. 2017. PMID: 28159497
Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance.
Tosoian JJ, Patel HD, Mamawala M, Landis P, Wolf S, Elliott DJ, Epstein JI, Carter HB, Ross AE, Sokoll LJ, Pavlovich CP. Tosoian JJ, et al. Among authors: mamawala m. Prostate Cancer Prostatic Dis. 2017 Sep;20(3):339-342. doi: 10.1038/pcan.2017.16. Epub 2017 Apr 18. Prostate Cancer Prostatic Dis. 2017. PMID: 28417979 Free PMC article.
49 results